ATE466088T1 - Zufällige integration von polynukleotide nach in vivo linearisierung - Google Patents
Zufällige integration von polynukleotide nach in vivo linearisierungInfo
- Publication number
- ATE466088T1 ATE466088T1 AT02798716T AT02798716T ATE466088T1 AT E466088 T1 ATE466088 T1 AT E466088T1 AT 02798716 T AT02798716 T AT 02798716T AT 02798716 T AT02798716 T AT 02798716T AT E466088 T1 ATE466088 T1 AT E466088T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- polynucleotides
- random integration
- vector
- polynucleotide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31881801P | 2001-09-14 | 2001-09-14 | |
| US33063901P | 2001-10-26 | 2001-10-26 | |
| PCT/EP2002/010224 WO2003025183A2 (en) | 2001-09-14 | 2002-09-12 | Random integration of a polynucleotide after in vivo linearization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE466088T1 true ATE466088T1 (de) | 2010-05-15 |
Family
ID=26981685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02798716T ATE466088T1 (de) | 2001-09-14 | 2002-09-12 | Zufällige integration von polynukleotide nach in vivo linearisierung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7098031B2 (de) |
| EP (1) | EP1427828B1 (de) |
| JP (1) | JP4436130B2 (de) |
| AT (1) | ATE466088T1 (de) |
| AU (1) | AU2002333832B2 (de) |
| DE (1) | DE60236182D1 (de) |
| DK (1) | DK1427828T3 (de) |
| ES (1) | ES2342159T3 (de) |
| WO (1) | WO2003025183A2 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7102055B1 (en) * | 1997-11-18 | 2006-09-05 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
| NZ503859A (en) * | 1997-11-18 | 2003-02-28 | Pioneer Hi Bred Int | Non-identical minimal recombination sites (FRT) which are non-identical for targeted integration of nucleotide sequences into transformed plants |
| WO2000046385A1 (en) * | 1999-02-03 | 2000-08-10 | The Children's Medical Center Corporation | Gene repair involving in vivo excision of targeting dna |
| AU2002350039A1 (en) | 2001-10-29 | 2003-05-12 | Renovis, Inc. | Method for isolating cell-type specific mrnas |
| FR2879622B1 (fr) * | 2004-12-17 | 2008-02-01 | Agronomique Inst Nat Rech | Procede in vitro de production d'ovocytes ou d'oeufs presentant une modification genomique ciblee |
| WO2006074956A1 (en) * | 2005-01-14 | 2006-07-20 | Bayer Bioscience N.V. | Improved plant transformation methods |
| EP1907553B1 (de) | 2005-07-18 | 2012-08-22 | Pioneer Hi-Bred International Inc. | Modifizierte frt-rekombinationsstellen und verwendungsverfahren |
| US7663019B2 (en) * | 2006-05-24 | 2010-02-16 | North Carolina State University | Transgenic snakes and methods of making |
| CA2688834C (en) | 2007-06-01 | 2020-01-07 | Ronald Buelow | Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| BRPI0816750A2 (pt) | 2007-06-29 | 2015-09-29 | Pioneer Hi Bred Int | métodos para alterar o genoma de uma célula de planta monocotiledônea e para modificar uma sequência alvo genômica endógena específica e planta de milho |
| WO2009114321A2 (en) | 2008-03-11 | 2009-09-17 | Precision Biosciencs, Inc. | Rationally-designed meganucleases for maize genome engineering |
| WO2009114185A2 (en) * | 2008-03-12 | 2009-09-17 | The Rockefeller University | Methods and compositions for translational profiling and molecular phenotyping |
| AU2009241351A1 (en) * | 2008-04-28 | 2009-11-05 | Precision Biosciences, Inc. | Fusion molecules of rationally-designed DNA-binding proteins and effector domains |
| WO2011117249A1 (en) | 2010-03-22 | 2011-09-29 | Philip Morris Products S.A. | Modifying enzyme activity in plants |
| AR085302A1 (es) | 2011-02-24 | 2013-09-18 | Sanofi Sa | Metodo de produccion de anticuerpos sialilados |
| CA2865097A1 (en) * | 2012-02-20 | 2013-08-29 | Advanced Tactical Ordnance LLC | Chimeric dna identifier |
| AU2013274542B2 (en) | 2012-06-12 | 2017-03-30 | Syngenta Crop Protection Ag | Methods and compositions for determination of vector backbone in a nucleic acid sample |
| WO2014083379A1 (en) | 2012-11-30 | 2014-06-05 | Institut Pasteur | Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock |
| EP3233897B1 (de) | 2014-12-19 | 2021-02-17 | Universite de Nantes | Anti-il-34-antikörper |
| USD765215S1 (en) | 2015-01-22 | 2016-08-30 | United Tactical Systems, Llc | Non-lethal projectile |
| US9766049B2 (en) | 2015-01-27 | 2017-09-19 | United Tactical Systems, Llc | Aerodynamic projectile |
| WO2017153432A1 (en) | 2016-03-07 | 2017-09-14 | Pierre Fabre Medicament | A new universal method to capture and analyze adcs for characterization of drug distribution and the drug-to-antibody ratio in biological samples |
| US12016313B2 (en) | 2017-01-19 | 2024-06-25 | Omniab Operations, Inc. | Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci |
| CN107372348A (zh) * | 2017-08-31 | 2017-11-24 | 广西沙田仙人滩农业投资有限公司 | 一种绿壳蛋鸡育虫生态养殖方法 |
| ES2920283T3 (es) | 2017-12-05 | 2022-08-02 | Progastrine Et Cancers S A R L | Terapia de combinación entre un anticuerpo antiprogastrina y la inmunoterapia para tratar el cáncer |
| EP3759492A1 (de) | 2018-02-27 | 2021-01-06 | ECS-Progastrin SA | Progastrin als biomarker für immuntherapie |
| IL280199B2 (en) | 2018-07-20 | 2025-08-01 | Pf Medicament | Receptor for vista |
| WO2020033456A1 (en) * | 2018-08-06 | 2020-02-13 | Nemametrix Inc | Homologous recombination reporter construct and uses thereof |
| EP3856229A1 (de) | 2018-09-28 | 2021-08-04 | Pierre Fabre Medicament | Neue immunzytokine zur behandlung von krebs |
| EP4025606A1 (de) | 2019-09-04 | 2022-07-13 | Y-Biologics Inc. | Anti-vsig4-antikörper oder antigenbindendes fragment und verwendungen davon |
| US20230227559A1 (en) | 2019-12-10 | 2023-07-20 | Institut Pasteur | New antibody blocking human fcgriiia and fcgriiib |
| EP3889183A1 (de) | 2020-04-01 | 2021-10-06 | Pierre Fabre Medicament | Proteinkomplex mit einem immunzytokin |
| KR20230156727A (ko) | 2021-03-03 | 2023-11-14 | 피에르 파브르 메디카먼트 | 항-vsig4 항체 또는 이의 항원 결합 단편 및 용도 |
| EP4172212A1 (de) | 2021-04-30 | 2023-05-03 | Pierre Fabre Medicament | Neuer stabiler anti-vista-antikörper |
| WO2023213814A1 (en) | 2022-05-02 | 2023-11-09 | Pierre Fabre Medicament | New formulation of anti vista antibody |
| WO2024121380A1 (en) | 2022-12-08 | 2024-06-13 | Pierre Fabre Medicament | Vaccinal composition and adjuvant |
| EP4688830A1 (de) | 2023-04-07 | 2026-02-11 | Commissariat à l'Energie Atomique et aux Energies Alternatives | Verwendung von antikörpern gegen endothelinrezeptor b für diagnostische und therapeutische anwendungen |
| WO2025262278A1 (en) | 2024-06-21 | 2025-12-26 | Institut Pasteur | A neurovita short interfering peptide suitable for neuroprotection and neuroregeneration and uses thereof |
| WO2025262307A2 (en) | 2024-06-21 | 2025-12-26 | Institut Pasteur | Vhh suitable to vectorize molecules intracellularly |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792632A (en) * | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US5474896A (en) * | 1992-05-05 | 1995-12-12 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
-
2002
- 2002-09-12 EP EP02798716A patent/EP1427828B1/de not_active Expired - Lifetime
- 2002-09-12 AU AU2002333832A patent/AU2002333832B2/en not_active Expired
- 2002-09-12 DK DK02798716.3T patent/DK1427828T3/da active
- 2002-09-12 AT AT02798716T patent/ATE466088T1/de active
- 2002-09-12 DE DE60236182T patent/DE60236182D1/de not_active Expired - Lifetime
- 2002-09-12 ES ES02798716T patent/ES2342159T3/es not_active Expired - Lifetime
- 2002-09-12 JP JP2003529956A patent/JP4436130B2/ja not_active Expired - Lifetime
- 2002-09-12 WO PCT/EP2002/010224 patent/WO2003025183A2/en not_active Ceased
- 2002-09-13 US US10/242,664 patent/US7098031B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002333832B2 (en) | 2007-07-26 |
| DE60236182D1 (de) | 2010-06-10 |
| DK1427828T3 (da) | 2010-07-19 |
| WO2003025183A2 (en) | 2003-03-27 |
| AU2002333832B9 (en) | 2003-04-01 |
| EP1427828A2 (de) | 2004-06-16 |
| JP4436130B2 (ja) | 2010-03-24 |
| WO2003025183A3 (en) | 2003-08-28 |
| US20030106077A1 (en) | 2003-06-05 |
| JP2005503161A (ja) | 2005-02-03 |
| EP1427828B1 (de) | 2010-04-28 |
| US7098031B2 (en) | 2006-08-29 |
| ES2342159T3 (es) | 2010-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60236182D1 (de) | Zufällige integration von polynukleotide nach in vivo linearisierung | |
| WO2019103442A3 (ko) | CRISPR/Cpf1 시스템을 이용한 유전체 편집용 조성물 및 이의 용도 | |
| BR0011499A (pt) | Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado | |
| PL1941045T3 (pl) | Zastosowanie sekwencji kwasu nukleinowego do wytwarzania transgenicznej rośliny o zwiększonej tolerancji na suszę | |
| ATE330007T1 (de) | Verfahren zur erhöhung der expression von endogenen oder exogenen genprodukten in pflanzen | |
| CY1107119T1 (el) | Κλωνωση και εκφραση μιας ανθεκτικης εις τα οξεα εξωκυτταρικης λιπασης yarrowia lipolytica | |
| AR014155A1 (es) | Proteina aislada involucrada en la resistencia a nematodos, secuencia de adn aislada, vector de transformacion, planta, semillas y metodo para aumentarla resistencia a nematodos en una planta | |
| DK1151085T3 (da) | Nukleinsyremolekyler, der koder for alternansucrase | |
| WO2004009761A3 (en) | Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing | |
| EP2169069A3 (de) | Stressbedingte Phosphataseproteine und Verfahren zu deren Verwendung für Pflanzen | |
| DE60035272D1 (de) | Verbesserte methode zur agrobakterien-vermittelten transformation von baumwolle | |
| BR0009471A (pt) | Composições e processos para modificação de transcrição de gene | |
| ATE526818T1 (de) | Gentechnisch hergestellte wasserlinse | |
| HU914086D0 (en) | Method for explication of phytaze in plants | |
| ATE408698T1 (de) | Kommerzielle herstellung von aprotinin in pflanzen | |
| ATE471378T1 (de) | Dna-konstrukte und verfahren zur verbesserung der produktion kommerziell realisierbarer transgener pflanzen | |
| TR200200693T2 (tr) | Gen ifadesinin kontrolü için bitkisel düzenleyici sekanslar | |
| EE200200115A (et) | Taimedest saadav rasvhappe-desaturaas-geen | |
| WO2001081600A3 (en) | Transgenic plants | |
| DE60043470D1 (de) | Pflanzliche Defensine | |
| MXPA02012475A (es) | Captura de genes activados ires en plantas. | |
| ATE368121T1 (de) | Expressionskassetten zur bidirektionalen transgenen expression von nukleinsäuren in pflanzen | |
| DE10346611A1 (de) | Promotor zur epidermisspezifischen Transgenexpression in Pflanzen | |
| AR047590A1 (es) | Alteracion de la estructura de la raiz durante el desarrollo de la planta | |
| DE69919186D1 (de) | Transgene geminivirus-resistente pflanzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1427828 Country of ref document: EP |